Real Patient Experiences with
Repurposed Drugs against their Cancer
Thousands of cancer patients share their experiences with Fenbendazole, Ivermectin, Mebendazole, and Albendazole in YouTube comments and Facebook posts from medical doctors and researchers. We've done the work for you: collecting, paraphrasing, and organizing these experiences into a searchable database. Our goal is to make patient experiences accessible while always emphasizing that these are anecdotal accounts that should complement β never replace β professional medical advice.
Start Exploring Patient Stories
β οΈ Important Medical Disclaimer
This website presents patient-reported experiences only β these are anecdotal accounts, not scientific evidence. Scientific proof requires randomized, double-blind clinical trials. The medications discussed (Ivermectin, Fenbendazole, Mebendazole, Albendazole) are not FDA-approved for cancer treatment. Always consult a qualified healthcare professional before making any treatment decisions.
Explore Our Database
Comments Explorer
Browse our curated collection of patient experiences from YouTube comments. Medical doctors and PhD researchers discuss promising cancer treatments in their videos β viewers share their personal experiences with these medications in the comments.
Filter by cancer type, disease severity, medications used, treatment outcome, and who received treatment (self, family, friend, or pet).
Start exploring βSupplements & Protocols
Many patients combine their treatment with supplements and specific protocols. Browse our database by supplement (Vitamin D, Curcumin, CBD oil, etc.) or protocol (Joe Tippens, Keto diet, FLCCC, etc.).
Interactive filters help you find patient experiences with specific supplements and dietary approaches.
Explore supplements & protocols βFree Search
While the Comments Explorer uses structured filters based on pre-defined categories, Free Search lets you find comments using your own keywords.
Search for specific terms like "non-hodgkin", combine words with AND (e.g., "fenbendazole AND cbd oil "), or use OR to find alternatives (e.g., "keto OR fasting").
Search freely βExpert/Patient Videos
Watch interviews with medical professors and specialists discussing repurposed drugs for cancer treatment. Also featuring cancer patients sharing their personal treatment journeys.
Learn about the science behind Ivermectin, Fenbendazole, and other promising treatments.
Watch videos βInsights
Key findings from analyzing patient comments and case reports. What patterns emerge from hundreds of real-world experiences with repurposed medications?
Read insights βπ£ Share Your Experience β Help Others
Have you, a family member, a friend, or a pet used ivermectin, fenbendazole, or mebendazole? Your story helps others and may help researchers spot patterns worth studying. Every experience counts β whether it worked, partly worked, or did not help.
If you can, please tell us:
- ποΈ What kind of cancer, and what stage?
- π Which drug(s) were used β ivermectin, fenbendazole, mebendazole β and at what dose?
- πΏ Any supplements or protocols alongside them?
- π What was the outcome, and over what period of time?
- π€ Does this concern you, a family member, a friend, or an animal?
Or simply send an email to:
contact@cancerpatientstories.com
(If the button does not open your email program, copy the address above.)
Comments Explorer
Medical doctors and researchers discuss promising repurposed cancer treatments, see the "videos" page. Viewers and patients share their experiences with these medications like ivermectin, fenbendazole and mebendazole under the original YouTube video's. You can read their paraphrased (due to copyright) comment here, but the key message is reproduced as a ...quote... . Click on "To original comment" to read their often profound experience directly below the YouTube video.
β οΈ Important Disclaimer
This website presents patient-reported experiences only; these are anecdotal accounts, not scientific evidence. Scientific proof requires randomized, double-blind clinical trials. This site does not provide medical advice. Always consult a qualified healthcare professional before making any treatment decisions.
π‘ Tips for exploring
* Scroll through all comments or use the filters below to narrow down by cancer type, medication, or outcome. * For rare cancer types not in the filters (e.g., "squamous cell carcinoma"), use the Free Search page. * Select in Patient filter for self and read the impressive ...quotes ... from the patients. * Or read the quotes from what were always very serious cases: filter by pancreatic cancer, brain cancer, or stage 4. * These repurposed drugs do not always have the desired result, see the did not help filter for those experiences. * When you select multiple labels within the same filter (e.g. fenbendazole, ivermectin), results matching any of them will be shown. When you select labels across different filters (e.g. lung cancer, remission), only results matching all selected filters will be shown. * You see chemotherapy or radiation, etc. in the drug filter: this is always in combination with repurposed drugs.
β³ Loading comments database...
Free Search
Search through all comments using keywords
β οΈ Important Disclaimer
This website presents patient-reported experiences only. It does not provide medical advice.
π‘ Tips for free search
* Search for rare cancer types not listed in the Disease filter, such as squamous cell carcinoma or mesothelioma. * If you want to read about tumors that have shrunk by centimeters, search using cm. If you want to read about the dose taken, search using mg, for example. * Use AND to find comments containing both terms: e.g., quercetin AND zinc returns only comments mentioning both. In the Supplements page, selecting two labels returns comments matching either one (OR).
Supplements & Protocols Explorer
Browse patient experiences that mention supplements or treatment protocols alongside repurposed medications (ivermectin, fenbendazole, mebendazole). You can read their paraphrased (due to copyright) comment here, but the key message is reproduced as a ...quote... . Click on "To original comment" to read their often profound experience directly below the YouTube video.
β οΈ Important Disclaimer
Supplements and dietary changes should be discussed with healthcare providers, especially during cancer treatment, as some may interact with medications.
π‘ Notes about Supplements and Protocols
* When you select multiple labels within the same filter (e.g. curcumin, milk thistle), results matching any of them will be shown. When you select labels across different filters (e.g. a supplement and a protocol), only results matching all selected filters will be shown. * Many comments simply mention supplements without further details. Only comments that describe a specific experience with supplements are listed here.
No data loaded
Data is still loading. Please wait a moment and try again.
The file should include columns: supplements, protocol
π¬ Expert/Patient Videos
Medical professors and specialists discuss repurposed drugs for cancer treatment.
βΉοΈ About These Videos
These interviews feature medical doctors, professors, and researchers discussing their clinical experience and research on repurposed drugs. The videos are hosted on YouTube and other platforms. Click on a video to watch the full interview.
Mebendazole and Fenbendazole as alternative
Professor Thomas Seyfried published a groundbreaking treatise entitled: Cancer as a Metabolic Disease
π March 11, 2024Professor Thomas Seyfried elucidates a metabolic breakthrough: tumor cells and parasites exploit identical energy pathways. Benzimidazoles, specifically Mebendazole and Fenbendazole, are structurally similar agents that disrupt these shared metabolic routes. While Mebendazole shows particular efficacy for brain malignancies, Fenbendazole targets various solid tumors by inhibiting the same vital pathways. These repurposed drugs offer a non-toxic 'press-pulse' strategy, essentially starving cancer cells by exploiting their evolutionary similarities to parasites. This approach represents a critical shift toward targeting cancerβs metabolic vulnerabilities, providing a safe, accessible adjunct to traditional oncological protocols. (3 minutes)
Ivermectin and mebendazole, 84% benefit in cancer
Dr. John Campbell, MSc Health Science, Ph.D. Bioscience
π April 16, 2026A prospective study reveals that combining Ivermectin and Mebendazole shows significant promise for cancer treatment. In a cohort of 197 patients, 84.4% experienced positive clinical outcomes, including tumor regression or stabilization across various cancer types. These repurposed, generic drugs provide a low-cost, low-toxicity alternative to conventional chemotherapy, which costs significantly more. The drugs work synergistically by disrupting microtubules, inhibiting angiogenesis, and targeting cancer stem cells. However, the speaker notes that large-scale clinical trials remain absent due to low profit potential for pharmaceutical companies, calling for urgent independent research to validate and further investigate these potentially life-saving therapeutic benefits for patients. (25 minutes)
Ivermectin and cancer
Dr. William Makis (right), Assistant Clinical Professor & Nuclear Medicine Physician, 110+ peer-reviewed medical publications, 900,000+ followers on social media
π February 4, 2025Dr. William Makis presents compelling preclinical and anecdotal evidence for ivermectin in advanced cancers. Multiple case reports show dramatic tumor regression and long-term remission in stage 4 patients who failed conventional therapies. Ivermectin disrupts cancer cell metabolism, induces apoptosis, inhibits angiogenesis and metastasis, and enhances immune recognition. Despite robust lab data and decades of safety use for parasites, large randomized human trials are absentβlargely because ivermectin lost patent protection in the 1990s and offers no profit incentive. Dr. Makis argues this financial barrier, not lack of efficacy, explains the absence of mainstream research. (6 minutes)
Fen ben cancer and hard science
Dr. William Makis (right), Assistant Clinical Professor & Nuclear Medicine Physician, 110+ peer-reviewed medical publications, 900,000+ followers on social media
π February 4, 2025Dr. William Makis presents compelling evidence for repurposed antiparasitics in advanced cancer. Terminal patient Joe Tippens achieved complete remission from stage 4 small cell lung cancer using fenbendazole after failing conventional therapy. Stanford University published a case series of three patients with stage 4 disease who became cancer-free with fenbendazole following multiple lines of failed chemotherapy. Mebendazole is now in clinical trials for colon, prostate and paediatric brain cancers. These agents exploit cancer-specific pathways, including glucose transporter blockade and apoptosis induction. Extensive preclinical data confirm safety and synergy with chemotherapy. (16 minutes)
Complete remissions in stage 4 cancers
Nicolas Hulscher, Master of Public Health, Epidemiology, Epidemiologist & Foundation Administrator at McCullough Foundation
π April 30, 2026In this short video, epidemiologist Nicolas Hulscher highlights emerging peer-reviewed evidence showing complete remissions of Stage IV cancers using anti-parasitic drugs Ivermectin and Fenbendazole/Mebendazole. He references Mel Gibsonβs account β shared on Joe Roganβs podcast β of three friends who recovered from Stage IV cancer after using these repurposed drugs. Hulscher notes hundreds of studies demonstrating over 12 distinct anti-cancer mechanisms across multiple cancer types. He also cites a recent study where intranasal nano-ivermectin reduced glioblastoma brain tumors by 70% in rats within 10 days, with zero toxicity. The message: inexpensive, long-used medications are showing promising results against advanced cancer. (1 minute)
Ivermectin on Cancer
Dr. Kathleen Ruddy, breast cancer surgeon, principal investigator, Observational Cancer Study, inventor with medical patents
π August 20, 2024Dr. Kathleen Ruddy was initially skeptical about ivermectin. After extensive literature research, she discovered more than 20 years of scientific evidence for its anti-cancer effect. In a patient with stage 4 prostate cancer, the PSA dropped from hundreds to 1.3 after ivermectin. Multiple bone metastases disappeared, and he regained his vitality. A second patient with two unresectable esophageal tumors saw both tumors completely disappear on scan. These remarkable results underscore the promising potential of repurposed drugs such as ivermectin in advanced cancer. (10 minutes)
New Hope for Cancer Treatment
Dr. Memet Isik (Canada)
π January 20, 2025In this video from the Holistic Cancer Care Channel, Dr. Memet Isik explores the growing interest in repurposed anti-parasitic drugs fenbendazole and ivermectin as potential cancer treatments. Fenbendazole disrupts microtubules and glucose metabolism in cancer cells, while ivermectin inhibits the Wnt/Ξ²-catenin pathway, both potentially leading to cell death. Preclinical studies and anecdotal reports suggest benefits against various cancers, but the video stresses these are experimental findings only. No clinical trials have yet confirmed safety or efficacy in humans. It outlines popular anecdotal protocols (e.g., fenbendazole 222 mg, 3 days on/4 days off; ivermectin 0.2β0.4 mg/kg, 2β3 times weekly) and warns viewers to consult qualified doctors before any use. (10 minutes)
The Anticancer Potential of Ivermectin and Fenbendazole
Dr. Micah Yu, Rheumatologist
π June 25, 2025Dr. Micah Yu explores the anti-cancer potential of Ivermectin and Fenbendazole. While lab and animal studies show promise across various cancer types, robust human clinical evidence is currently lacking. Consequently, standard dosages aren't established, and oncologists do not yet include them in treatment protocols. However, a human trial is underway at City of Hope. Similarly, Fenbendazole, primarily an animal medication, gained attention through a case report of a lung cancer patientβs recovery alongside supplements like CBD and turmeric. Though these repurposed drugs are inexpensive and accessible, Dr. Yu emphasizes that more human research is essential to validate their efficacy and safety. (6 minutes)
Cancer treatment basics
Professor of Oncology Angus Dalgleish (left)
π June 10, 2025Professor Angus Dalgleish emphasizes the critical role of innate immunity in advanced cancer control. He highlights three synergistic, low-risk interventions: high-dose vitamin D (maintaining levels >100 nmol/L) to restore immune function, low-dose naltrexone (LDN, 3β4.5 mg nightly) to block IL-6-driven inflammation and enhance chemotherapy/radiotherapy sensitivity, and IMM-101 (heat-killed Mycobacterium) to powerfully stimulate innate immunity and T-cell responses. In stage IV melanoma with liver metastasesβclassically terminalβhe has observed exceptional responses and prolonged survival using these agents. These affordable, repurposed approaches target fundamental immune pathways, offering meaningful benefit. (15 minutes)
Fenbendazole and Cancer: Evidence, Myths & Risks!
Dr. Eloy Roman MD, hematologist-oncologist
π March 7, 2026In this video, Dr. Eloy Roman presents the current scientific facts about fenbendazole as a potential cancer treatment. He notes a large amount of anecdotal evidence on social media from patients who claim benefits, but stresses there are no randomized clinical trials in humans proving its safety or effectiveness.Preclinical studies (lab and animal models) show promising mechanisms, such as microtubule disruption and proteasome inhibition, similar to some existing chemotherapies. However, Dr. Roman warns that most drugs successful in preclinical testing never reach clinical approval. He highlights many unanswered questions regarding dosage, duration, combination with other therapies, and applicability across different cancer types. (8 minutes)
Florida put Spotlight on Ivermectin
Florida governor Ron DeSantis & first lady Casey DeSantis
π September 25, 2025Florida has allocated $60 million to fund high-impact cancer research, with a dedicated focus on repurposed generic drugs. A key component targets ivermectin, a low-cost medication (approximately 77 cents per pill) that gained attention after anecdotal reportsβincluding Mel Gibson on Joe Roganβof stage IV cancer patients achieving remission. The initiative aims to rigorously investigate whether ivermectin holds genuine anti-cancer potential, addressing the lack of large-scale trials due to its off-patent status and limited commercial incentive. State leaders emphasize accountability, prevention, and delivering real hope through meaningful, outcome-driven science for patients facing advanced disease. (16 minutes)
How Metabolic Therapy is Changing Lives (patients)
Professor Thomas Seyfried published a groundbreaking treatise entitled: Cancer as a Metabolic Disease
π November 7, 2023Professor Thomas Seyfried views cancer as a metabolic disease driven by defective oxidative phosphorylation, forcing tumor cells to ferment glucose and glutamine for survival. His therapy restricts these fuels through ketogenic/carnivore diets, intermittent fasting, and glutamine-targeting agents (e.g. DON), often combined with lower-dose chemotherapy. This non-toxic metabolic approach degrades tumors while restoring overall health, avoiding the collateral damage of standard treatments. Four patients share remarkable outcomes: Ronnie (stage 4 ovarian cancer) became cancer-free after 15β18 months; Jeff (stage 4 colon cancer) is thriving after 15β18 months; Diane (stage 2B ovarian cancer) saw markers plummet; Maggie (wife of Brad with stage 4 cancer) achieved remission in one year. (65 minutes)
Ivermectin & Fenbendazole: How Iβm Using Them to Fight Stage 4 Cancer (patient)
Carli Williams
π March 7, 2025Carli Williams, a stage 4 breast cancer patient (second diagnosis after chemo, radiation, and double mastectomy), shares why she is adding fenbendazole and ivermectin to her treatment. She discovered the protocol through multiple βdivineβ coincidences and was inspired by stories of success, including a man whose prostate tumors shrank dramatically. She views it as a low-risk βasymmetric betβ with minimal side effects. In the video she demonstrates her daily protocol: ivermectin horse paste (2 notches), fenbendazole combined with curcumin, vitamin E, liver support, and a CBG tincture, all taken with fat (her coconut-milk chia pudding). She stresses this is not medical advice and will share her upcoming PET scan results. (15 minutes)
Cancer Update (I'm much better off) (patient)
Eke Acres
π March 19, 2026In this video, this cancer patient explains his decision since September 2025 to completely stop all conventional healthcare and insurance after massive medical bills from cancer treatment nearly wiped out his savings β dropping from nearly $20,000 to $7,000 in under six months. Instead, he adopted a self-managed regimen using Ivermectin and Fenbendazole. The results have been remarkable: not only has his cancer improved significantly, but chronic issues like severe eye infections have completely disappeared. He now feels healthier while saving money. He criticizes the medical system as greedy and vows to buy only vintage items and cut unnecessary expenses going forward. Many followers report similar positive outcomes. (13 minutes)
Q&A with Joe Tippens (patient)
Joe Tippens
π April 16, 2025In this Facebook Live Q&A, Joe Tippens and his team discuss the current Joe Tippens Protocol for cancer. Fenbendazole is taken at 222 mg daily, 7 days a week for active cancer. For maintenance (after 2 years NED), the recommendation is 3 days on / 4 days off. The protocol also includes four specific Ultra Botanica supplements (Enco products) designed to enhance absorption and target multiple cancer pathways. Joe emphasizes that the protocol can be used alongside conventional treatments (chemotherapy, radiation, immunotherapy), but patients should work with a qualified integrative or functional practitioner. He notes that combining fenbendazole, mebendazole, and ivermectin is not recommended due to potential neurotoxicity. The focus is on an adjunctive, metabolic approach rather than replacement therapy. (60 minutes)
β Support This Project
This website is a personal project. Your support helps with running costs and continued development β there are many more features and data sources planned.
β You can Buy Me a Coffeeπ Data Insights
Patterns and observations drawn from patient comments and case reports in our database.
β οΈ Important Note
These insights are derived from what patients and others write in their comments and posts. They are observational patterns from anecdotal reports β not scientific conclusions. They have not been verified through clinical trials. Always consult a qualified healthcare professional for medical decisions.
Statistics from 1,293 Patient Comments (sep 1, 2026)
Sep 1, 2026These comments were written by patients themselves (54%), family members (23%), friends (16%), and pet owners (7%) in YouTube comments.
Important context: these numbers reflect a self-selection bias. Patients who experience positive results are far more likely to post about it than those who don't. The true effectiveness rate is unknown and cannot be determined from anecdotal comments. Nevertheless, the 12.5% "did not help" responses show that negative outcomes are also reported.
Outcomes by Cancer Type
Statistics from 1,293 comments (Sep 1, 2026)Remission rates vary considerably across cancer types. The table below shows the 16 cancer types with at least 10 reports.
| Cancer Type | Remission | % | Improved | % | Did Not Help | % | Total |
|---|---|---|---|---|---|---|---|
| Cancer, type not specified | 156 | 34.0% | 234 | 51.0% | 69 | 15.0% | 459 |
| Bladder cancer | 21 | 55.3% | 15 | 39.5% | 2 | 5.3% | 38 |
| Blood cancer | 17 | 39.5% | 21 | 48.8% | 5 | 11.6% | 43 |
| Bone cancer | 10 | 52.6% | 7 | 36.8% | 2 | 10.5% | 19 |
| Brain cancer | 4 | 20.0% | 13 | 65.0% | 3 | 15.0% | 20 |
| Breast cancer | 53 | 40.8% | 62 | 47.7% | 15 | 11.5% | 130 |
| Cervical cancer | 5 | 38.5% | 7 | 53.8% | 1 | 7.7% | 13 |
| Colon cancer | 37 | 45.1% | 33 | 40.2% | 12 | 14.6% | 82 |
| Kidney cancer | 2 | 18.2% | 9 | 81.8% | 0 | 0.0% | 11 |
| Liver cancer | 10 | 28.6% | 23 | 65.7% | 2 | 5.7% | 35 |
| Lung cancer | 51 | 45.1% | 53 | 46.9% | 9 | 8.0% | 113 |
| Lymph cancer | 13 | 50.0% | 10 | 38.5% | 3 | 11.5% | 26 |
| Ovarian cancer | 9 | 39.1% | 11 | 47.8% | 3 | 13.0% | 23 |
| Pancreatic cancer | 14 | 38.9% | 18 | 50.0% | 4 | 11.1% | 36 |
| Prostate cancer | 37 | 23.0% | 97 | 60.2% | 27 | 16.8% | 161 |
| Skin cancer | 34 | 45.3% | 39 | 52.0% | 2 | 2.7% | 75 |
| Stomach cancer | 5 | 50.0% | 4 | 40.0% | 1 | 10.0% | 10 |
Notable observations:
β’ Pancreatic cancer shows the highest remission rate (51.7%) β remarkable given its normally dire prognosis. However, the sample size is small (29 comments).
β’ Skin cancer has the lowest failure rate β only 1 out of 73 reports (1.4%) said the treatment did not help.
β’ Prostate cancer has many reports (135) but a relatively low remission rate (20%). Most patients report improvement rather than complete remission, often measured by PSA levels. This could also be because prostate cancer grows slow and becomes chronic, rather than achieving full remission.
β’ Brain cancer stands out with only 5% remission. However, 80% of patients still report improvement, suggesting the medications may help manage the disease even if full remission is rare.
Stage 4 Patients Show Remarkable Results
Statistics from 1,293 comments (Sep 1, 2026)| Remission % | Improved % | Did Not Help % | Total | |
|---|---|---|---|---|
| Stage 4 Patients | 42.0% | 49.1% | 8.9% | 336 |
Notable observations:
Of the 336 patients who reported having some form of cancer, specifically stage 4, 42.0% achieved full remission and 49.1% reported improvement. Only 8.9% said the treatment did not help β a lower failure rate than the overall population (12.5%).
Repurposed Drugs: Single Use and Combinations
Statistics from 1,293 comments (Sep 6, 2026)| Remission % | Improved % | Did Not Help % | Total | |
|---|---|---|---|---|
| fenbendazole | 44.4% | 45.6% | 10.0% | 349 |
| ivermectin | 38.2% | 52.6% | 9.2% | 304 |
| mebendazole | 36.8% | 52.6% | 10.5% | 19 (small sample) |
| fenbendazole + ivermectin | 31.5% | 50.5% | 18.0% | 289 |
| fenbendazole + mebendazole | 57.1% | 42.9% | 0.0% | 7 (small sample) |
| ivermectin + mebendazole | 28.3% | 48.4% | 23.2% | 95 |
| fenbendazole + ivermectin + mebendazole | 25.0% | 58.3% | 16.7% | 24 |
Notable observations:
When used alone, fenbendazole shows a slightly higher remission rate (44.4%, n=349) than ivermectin (38.2%, n=304), with similar failure rates (10.0% vs. 9.2%). The two most-used single drugs also have the largest sample sizes, so their figures are the most stable in this table.
Among the combinations, fenbendazole + ivermectin is by far the most reported (n=289). The other combinations are much smaller: mebendazole alone (19), fenbendazole + mebendazole (7), and the three-drug combination (24) are all too small to draw conclusions from β a single case shifts their percentages by several points.
These numbers should not be read as a ranking of effectiveness. They cannot tell you which drug or combination "works best," for several reasons. The groups are not comparable: different drugs are chosen for different cancers, stages, and situations. For example, mebendazole is often chosen for brain tumours, which sit in a hard-to-reach location with a poorer outlook β so a lower remission rate in a mebendazole-containing group may reflect the difficulty of those cancers, not the drug. Patients who combine several drugs are also often those whose disease is more advanced or resistant, which can pull combination figures down independently of the drugs themselves.
As everywhere on this page, these are self-selected, self-reported anecdotes. They describe what people reported taking, not a controlled comparison β and they cannot establish that any drug caused any outcome.
How Repurposed Drugs Are Used: Alone or Alongside Conventional Treatment
Statistics from 1,293 comments (Sep 6, 2026)Among the 1,288 comments mentioning a repurposed drug (ivermectin, fenbendazole, or mebendazole), we distinguished three situations: those who never used conventional therapy, those who had conventional therapy earlier and then stopped it to use only repurposed drugs, and those who used repurposed drugs at the same time as conventional therapy.
| Situation | Remission % | Improved % | Did Not Help % | Total |
|---|---|---|---|---|
| Only repurposed drugs (never conventional) | 37.3% | 49.6% | 13.1% | 1,093 |
| Conventional first, stopped, now only repurposed | 25.5% | 59.6% | 14.9% | 47 |
| Repurposed + concurrent conventional therapy | 39.9% | 52.7% | 7.4% | 148 |
Notable observations:
To separate patients who stopped conventional therapy from those using it at the same time, each comment mentioning both was read individually (the drug field alone cannot tell the difference). Where the timing was unclear, the comment was counted as concurrent β the more cautious choice, which does not credit the repurposed drug alone.
Interpret with great care. The "stopped conventional" group is small (47 comments), so its percentages are fragile. And in the concurrent group, any benefit cannot be attributed to the repurposed drugs β the conventional therapy was running at the same time. These are self-selected anecdotes, not evidence of effectiveness.
Why Did They Stop Conventional Therapy?
Statistics from 1,293 comments (Sep 6, 2026)For the 47 patients who had conventional therapy and then stopped it to use only repurposed drugs, we looked at the reason they gave. A patient may fall under more than one reason; the most clearly stated one was chosen.
| Reason given | Count | Example (in the commenter's words) |
|---|---|---|
| Completed the planned course | 20 | "I finished chemo and 25 sessions of targeted radiotherapy" |
| Conventional therapy was not working | 9 | "did the chemo treatment, which didn't work" |
| Personal choice / declined | 7 | "The doctor suggested breast removal, I said no" |
| Side effects | 5 | "Chemo almost killed me" |
| Reason unclear | 5 | β |
| Doctors offered no more options | 1 | "it's not working, plan your funeral" |
Notable observations:
Notably, the largest group had simply completed their conventional treatment before continuing with repurposed drugs β so "stopped" does not usually mean "abandoned treatment against advice." With only 47 comments, these counts are indications, not statistics.
Did Patients Tell Their Oncologist?
Statistics from 1,293 comments (Sep 6, 2026)Among the 148 patients using repurposed drugs at the same time as conventional therapy, we looked at whether they told their oncologist β and how the doctor reacted.
| Did they tell the oncologist? | Count | Example (in the commenter's words) |
|---|---|---|
| Not mentioned in the comment | 110 | β |
| Deliberately did not tell | 20 | "She never told her oncologist⦠she knew he would tell her to stop" |
| Told β doctor neutral | 6 | "Oncologist just looks confusedβ¦ never seen recovery before" |
| Told β doctor supportive | 6 | "keep doing what you are doing" |
| Told β doctor opposed | 6 | "we told her oncologists and they of course dismissed the idea" |
β οΈ An important safety point. Of the patients who mentioned it, a notable number deliberately did not tell their oncologist about the repurposed drugs. This can be concerning: some repurposed drugs can interact with conventional treatments or affect the liver, and doctors can only account for what they know about. If you are considering these drugs, telling your treating physician is safer than hiding it.
Reactions from doctors who were told were mixed β some neutral, some supportive, some opposed. Most comments did not say whether the doctor was informed at all.
Animals Respond Similarly to Humans
Statistics from 1,293 comments (Sep 1, 2026)| Remission % | Improved % | Did Not Help % | Total | |
|---|---|---|---|---|
| Animals | 32.0% | 52.3% | 15.1% | 86 |
Notable observations:
86 comments describe treatment of pets (mostly dogs). Animal outcomes mirror human results: 32.6% remission, 52.3% improved, 15.1% did not help. The slightly higher failure rate may reflect that animals are often treated at a very late stage when the vet has given up.
Other key findings
Statistics from 1,293 comments (Sep 1, 2026)When It Does Not Work
121 comments (9.2%) report that the treatment did not help. The cancers most associated with failure are prostate cancer (19 reports, 14.1% failure rate) and colon cancer (11 reports, 13.3% failure rate). Among the failures, only 20 patients mentioned stage 4, suggesting that late-stage cancer is not the primary predictor of treatment failure.
Absorption with Fatty Food
Many patients report taking fenbendazole with fatty food (olive oil, MCT oil, peanut butter) to improve absorption. Several comments reference published research showing significantly higher bioavailability when taken with fats.
Liver Function Monitoring
Monitoring liver function is frequently mentioned as important. Some patients report balancing fenbendazole with supplements like milk thistle and alpha lipoic acid to manage liver enzyme levels. Or a number of patients report taking medications in cycles rather than continuously β for example, 3 days on and 4 days off, 5 days on and 2 days off, etc.
Vitamin Supplements Are Widely Combined
Combining repurposed medications with vitamin supplements is very common, especially vitamin D3 and vitamin C.
β Support This Project
This website is a personal project. Your support helps with running costs and continued development β there are many more features and data sources planned.
β You can Buy Me a CoffeeβΉοΈ About Cancer Patient Stories
π¬ Contact Us
General inquiries
contact@cancerpatientstories.com
I'd also love to hear from you if you spot any inaccuracies in comments or have ideas for improving this website.
Share your story
contact@cancerpatientstories.com
We would love to hear about your experience with fenbendazole, ivermectin, mebendazole, or albendazole. Please include as much of the following as you can:
Please include: type of cancer and stage; who was treated (self / family / friend / animal); which repurposed drug(s) and dose; supplements or protocol used; the outcome and over what period of time.
π Website Timeline
Sep 1, 2026
π Website launch β cancerpatientstories.com goes live with initial database of patient experiences.
Sep 6, 2026
π Menu option Insights β 4 new tables added; these have been assigned the date Sep 6, 2026.
New milestones will be added here as the project grows.
π± How this website was born
In 2024 and 2025, I started watching videos about repurposed drugs being used by cancer patients. What struck me most were the thousands of comments underneath β real people sharing their experiences, their hopes, and their outcomes.
In mid-2025, I learned that a family member of a close friend had been diagnosed with stage 4 prostate cancer. On April 10, 2025, I sent him links to several videos about repurposed drugs. On January 1, 2026, I received an incredible message back: "Cancer is no longer visible on PET scan."
This story resonated with my circle of friends, who also know cancer patients. And that gave birth to this website. I wanted to give others the opportunity to learn from these videos and especially patient experiences β to collect, organize, and make them searchable in one place.
This website takes no position in the broader debate around repurposed medications. Its sole purpose is to make patient experiences accessible to those who are looking for them β nothing more, nothing less.
This is a personal project. I am not a medical professional. My goal is simply to make patient stories accessible to those who are looking for them.
β Support This Project
This website is a personal project. Your support helps with running costs and continued development β there are many more features and data sources planned.
β You can Buy Me a Coffee